June has seen a slew of executive hires, promotions, exits and layoffs across the healthcare sector. For example, CVS Health ...

The Supreme Court upheld the constitutionality of an Affordable Care Act provision requiring insurance coverage of certain preventive services without cost-sharing. Many healthcare leaders applauded ...

Hinge Health and Omada Health. During a recent panel discussion, venture capitalists shared lessons learned about health tech ...

Advanced materials and innovative construction design in hospital bed technology are increasingly being shown to help prevent HAIs, pressure injuries and falls. Integrated safety features such as ...

Cigna launched these tools to make the customer experience as seamless as possible, according to Chris DeRosa, executive vice president of business improvement and innovation at The Cigna Group ...

AHIP, an advocacy organization for health insurers, is sounding the alarm over the potential impact of the 2025 budget reconciliation legislation, which includes significant cuts to Medicaid and ...

If the One Big Beautiful Bill Act is signed into law, it would result in a $50.4 billion reduction in federal Medicaid spending on rural hospitals over the next decade, which could put 338 rural ...

AstraZeneca is paying CSPC Pharmaceutical Group $110 million up front to tap that China-based biotech’s artificial intelligence-driven technology for discovering and developing novel oral drugs ...

The Trump administration’s cancellation of $766 million in contracts to develop mRNA vaccines against potential pandemic flu viruses is the latest blow to national defense, former health ...

California’s SB553, the nation’s first comprehensive and multi-industry workplace violence prevention law, has been in effect for almost a year. Many other states are following suit with their ...

In this episode of the MedCity Pivot Podcast, editor-in-chief Arundhati Parmar, speaks with Helix CEO James Lu about his company and how far precision medicine has come.

Trump said this policy change is needed because high drug prices in the U.S. subsidize low drug prices in foreign markets, an imbalance that amounts to other countries getting a “free ride ...